Find a Tender
complete
Official procurement procedure
NCA30952 Perkin Elmer Opera, SE Funded, SCRM
Microscopes
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University Of Edinburgh: "NCA30952 Perkin Elmer Opera, SE Funded, SCRM". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | University Of Edinburgh | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: University Of Edinburgh
Market Analytics
Derived from OCDS awards & bid statistics
Published history for University Of Edinburgh. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 230 active published awards; 205 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity Of Edinburgh | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published26 Mar 2021, 15:56 GMT | Last source update26 Mar 2021, 15:56 GMT | Recurring procurementNot published |
ClassificationMicroscopes | ||
Delivery area | ||
OCIDocds-h6vhtk-029fe1 | ||
What is being bought
Opera Phenix® Plus
HIGH-CONTENT SCREENING SYSTEM
Opera Phenix® Plus is a high throughput microplate confocal imager for High-Content
Screening (HCS). It can acquire, analyze and manage fluorescence, brightfield and
digital phase contrast images.
What changed
From the official release history
- Status changed to complete
26 Mar 2021, 15:56 GMT - Official notice release published
26 Mar 2021, 15:56 GMT - Buyer information updated
26 Mar 2021, 15:56 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedUnder Regulation Reg 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015, a contracting authority may use the negotiated procedure without the prior publication in the case of a public contract, based on the following justification: Competition is absent for technical reasons (only if it is not caused by artificial narrowing down of the parameters of the procurement and no reasonable alternative or substitute exists)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
26 Mar 2021, 15:56 GMT - Award active
Not published · Not published - Contract active
Signed 25 Mar 2021, 00:00 GMT · £718,902
Commercial outcome and competition
Awards Perkin Elmer LAS Ltd Not published · Not published · active |
Contracts Contract £718,902 · signed 25 Mar 2021, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) electronicBids: 0 (lot 1) foreignBidsFromEU: 1 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
University Of Edinburgh
Contracting authority GB-FTS-2023Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThis purchase will ensure continuity of our data processing and experimental setup, Columbus is not interchangeable with other high content platforms currently on the market. If we purchased an alternative platform, it would also require additional licenses for new software and computer hardware, these collateral costs are beyond our current budgetary scope. The Opera Phenix Plus is the only high content screening system available on the market that: i) Will be equipped with up to 3 proprietary high NA automated water immersion objectives of different magnifications for shorter measurement times and improved z-resolution in 3D imaging. This technology is covered by two patent families, granted EP1386189 B1, US7304793 B2:” and EP1646902 B1, US7961384 B2:. It will allow us to visualise in 3D spheroids, organoids and embryos in higher resolution and clarity. This is one of the highest priority in our research scopes to have instrument capable of 3D imaging for 3D disease models. Additionally, it will let us resolve the very small details in cells like protein interaction and RNA localisation and perform neuronal assays (spine analysis, vesicles). ii) Employs a micro lens enhanced dual Nipkow spinning disk concept with proprietary confocal Synchrony Optics™ which separates excitation of adjacent fluorescence channels in time and space to reduce spectral crosstalk during simultaneous multicolor confocal imaging on average by 98%. This technology is covered by patent, granted US Patent 9,612,428. This will allow us to use more colours to be imaged simultaneously with unprecedented speed rendering images without crosstalk between colours making analysis data much easier. This is vital to analyse small details like intracellular organelles. Synchrony Optics™ is crucial for high throughput assays such as compound screens because it removes the need for image post processing reducing time and a storage. iii) Patent-pending PreciScan extension which determines the z-position of the object and use it in a re-scan. PreciScan allows to quickly find region of interest in low magnification and rescan it in higher magnification for more details. This feature is of most importance for our imaging needs allowing us to perform detection of rare events happening in cells, reduction of data load and increase of imaging speed. |